This study suggested that the presence of environmental factors other than CYP2C19 PM genotype influence platelet reactivity, which was similar to the result in our study although the patient backgrounds were different because they included subacute phase stroke patients. This evidence concerns the gene CYP2C19 and stroke disorder.